Coherus Oncology (CHRS) Debt Ratio: 2014-2025
Historic Debt Ratio for Coherus Oncology (CHRS) over the last 10 years, with Sep 2025 value amounting to 0.07.
- Coherus Oncology's Debt Ratio fell 21.14% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 21.14%. This contributed to the annual value of 0.11 for FY2024, which is 71.72% down from last year.
- According to the latest figures from Q3 2025, Coherus Oncology's Debt Ratio is 0.07, which was down 14.71% from 0.08 recorded in Q2 2025.
- Coherus Oncology's 5-year Debt Ratio high stood at 0.61 for Q1 2023, and its period low was 0.07 during Q2 2024.
- Its 3-year average for Debt Ratio is 0.24, with a median of 0.11 in 2024.
- Per our database at Business Quant, Coherus Oncology's Debt Ratio spiked by 359.28% in 2022 and then crashed by 87.06% in 2024.
- Quarterly analysis of 5 years shows Coherus Oncology's Debt Ratio stood at 0.11 in 2021, then surged by 359.28% to 0.51 in 2022, then declined by 22.29% to 0.40 in 2023, then plummeted by 71.72% to 0.11 in 2024, then dropped by 21.14% to 0.07 in 2025.
- Its Debt Ratio stands at 0.07 for Q3 2025, versus 0.08 for Q2 2025 and 0.17 for Q1 2025.